{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T12:33:08Z","timestamp":1793449988562,"version":"4.5.0"},"reference-count":24,"publisher":"Association of Avian Veterinarians (AAV)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Avian Medicine and Surgery"],"published-print":{"date-parts":[[2020,3,29]]},"abstract":"<jats:p>Aspergillosis is a common cause of morbidity and mortality in captive penguins. Itraconazole, an antifungal drug, is commonly used to treat aspergillosis infections in avian species; however, commercially available human formulations are costly, and studies have shown the effectiveness of compounded formulations to be unreliable. The US Food and Drug Administration (FDA) recently approved a veterinary formulation of itraconazole, Itrafungol, for use in cats. This study provides preliminary results from limited sampling evaluating whether this veterinary formulation is suitable for future studies in the African penguin (Spheniscus demersus). A 20 mg\/kg PO itraconazole dose was administered to 9 African penguins. Blood samples were taken over the course of 24 hours; each sample was collected from a different bird to minimize stress to the animals. Plasma was analyzed by high-performance liquid chromatography for concentrations of itraconazole. The drug was absorbed in all penguins, and plasma concentrations in 5 of 9 penguins (56%) were found to be greater than the established therapeutic dose of 1.0 \u00b5g\/ mL. To our knowledge, this is the first study that has investigated a 20 mg\/kg dose of itraconazole in a penguin species. The small sample size limits the conclusions that can be drawn from this preliminary study. Nonetheless, we demonstrate encouraging evidence that the FDA-approved formulation of oral itraconazole solution should be considered for future study as a cost-effective treatment for aspergillosis in African penguins and other avian species.<\/jats:p>","DOI":"10.1647\/1082-6742-34.1.52","type":"journal-article","created":{"date-parts":[[2020,3,29]],"date-time":"2020-03-29T02:14:38Z","timestamp":1585448078000},"page":"52-56","source":"Crossref","is-referenced-by-count":8,"title":["Preliminary Pilot Study of Itraconazole After a Single Oral Dose of a Veterinary Formulation Solution in African Penguins (Spheniscus demersus)"],"prefix":"10.1647","volume":"34","author":[{"given":"Selina M.","family":"Zalesak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos R.","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley A.","family":"Pich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark G.","family":"Papich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1222","reference":[{"key":"4","doi-asserted-by":"crossref","unstructured":"RS. Wallace,  \"Zoo and wild animal medicine.\"  , \"Sphenisciformes (Penguins).\" 82 (2015)","DOI":"10.1016\/B978-1-4557-7397-8.00010-4"},{"key":"1","unstructured":"G. Campbell,  \"Ir Vet J.\"  27, \"Aspergillosis in captive penguins.\" 29 (1973)"},{"key":"2","unstructured":"MR. Cranfield,  \"Zoo and Wild Animal Medicine.\"  , \"Sphenisciformes (penguins).\" 103 (2003)"},{"key":"3","unstructured":"EJ Flach, MF Stevenson, GM Henderson,  \"Vet Rec.\"  126, \"Aspergillosis in gentoo penguins (Pygoscelis papua) at Edinburgh Zoo, 1964 to 1988.\" 81 (1990)"},{"key":"5","unstructured":"A. Martel,  \"Current Therapy in Avian Medicine and Surgery.\"  , \"Aspergillosis.\" 63 (2016)"},{"key":"6","doi-asserted-by":"crossref","unstructured":"MW Hyatt, TA Georoff, HH Nollens,  \"J Zoo Wildl Med.\"  46, \"Voriconazole toxicity in multiple penguin species.\" 880 (2015)","DOI":"10.1638\/2015-0128.1"},{"key":"7","unstructured":"RS Wallace  and M Walsh  \"Penguin Husbandry Manual.\"  , \"Health.\" 86 (2005)"},{"key":"8","doi-asserted-by":"crossref","unstructured":"MW Hyatt, NP Wiederhold, WW Hope, et al.  \"J Zoo Wildl Med.\"  48, \"Pharmacokinetics of orally administered voriconazole in African penguins (Spheniscus demersus) after single and multiple doses.\" 352 (2017)","DOI":"10.1638\/2016-0160R2.1"},{"key":"9","doi-asserted-by":"crossref","unstructured":"DI Mawbdy, JC Whittemore, LE Fowler, et al.  \"J Am Vet Med Assoc.\"  252, \"Comparison of absorption characteristics of oral reference and compounded itraconazole formulations in healthy cats.\" 195 (2018)","DOI":"10.2460\/javma.252.2.195"},{"key":"10","doi-asserted-by":"crossref","unstructured":"AG Prentice  and A Glasmacher  \"J Antimicrob Chemother.\"  56, \"Making sense of itraconazole pharmacokinetics.\" i17 (2005)","DOI":"10.1093\/jac\/dki220"},{"key":"11","doi-asserted-by":"crossref","unstructured":"JS Hostetler, LH Hanson, DA Stevens,  \"Antimicrob Agents Chemother.\"  36, \"Effect of cyclodextrin on the pharmacology of antifungal oral azoles.\" 477 (1992)","DOI":"10.1128\/AAC.36.2.477"},{"key":"12","doi-asserted-by":"crossref","unstructured":"EM Bunting, N Abou-Madi, S Cox,  \"J Zoo Wildl Med.\"  40, \"Evaluation of oral itraconazole administration in captive Humboldt penguins (Spheniscus humboldti).\" 508 (2009)","DOI":"10.1638\/2009-0045.1"},{"key":"13","doi-asserted-by":"crossref","unstructured":"JA Smith, MG Papich, G Russell, et al.  \"J Zoo Wildl Med.\"  41, \"Effects of compounding on pharmacokinetics of itraconazole in black-footed penguins (Spheniscus demersus).\" 487 (2010)","DOI":"10.1638\/2010-0019.1"},{"key":"14","doi-asserted-by":"crossref","unstructured":"MA Zordan, MG Papich, AA Pich,  \"Am J Vet Res.\"  77, \"Population pharmacokinetics of a single dose of meloxicam after oral and intramuscular administration to captive lesser flamingos (Phoeniconaias minor).\" 1311 (2016)","DOI":"10.2460\/ajvr.77.12.1311"},{"key":"15","doi-asserted-by":"crossref","unstructured":"CR Sanchez, S Zalesak, AA Pich, et al.  \"J Vet Pharmacol Ther.\"  42, \"Population pharmacokinetics of itraconazole solution after a single oral administration in captive lesser flamingos (Phoeniconaias minor).\" 1 (2019)","DOI":"10.1111\/jvp.12721"},{"key":"16","doi-asserted-by":"crossref","unstructured":"MP Jones, SE Orosz, SK Cox, et al.  \"J Avian Med Surg.\"  14, \"Pharmacokinetic disposition of itraconazole in red-tailed hawks (Buteo jamaicensis).\" 15 (2000)","DOI":"10.1647\/1082-6742(2000)014[0015:PDOIIR]2.0.CO;2"},{"key":"17","unstructured":"SE Orosz, DL Frazier, EC Schroeder,  \"J Avian Med Surg.\"  10, \"Pharmacokinetic properties of itraconazole in blue-fronted Amazon parrots (Amazona aestiva aestiva).\" 168 (1996)"},{"key":"18","unstructured":"SE Orosz, EC Schroeder, SK Cox,  \"J Avian Med Surg.\"  9, \"The effects of formulation on the systemic availability of itraconazole in pigeons.\" 255 (1995)"},{"key":"19","doi-asserted-by":"crossref","unstructured":"AE Hasbach, DK Langlois, EJ Rosser, et al.  \"J Vet Intern Med.\"  31, \"Pharmacokinetics and relative bioavailability of orally administered innovator-formulated itraconazole capsules and solution in healthy dogs.\" 1163 (2017)","DOI":"10.1111\/jvim.14779"},{"key":"20","doi-asserted-by":"crossref","unstructured":"NA Forbes, GN Simpson, MF Goudswaard,  \"Vet Rec.\"  130, \"Diagnosis of avian aspergillosis and treatment with itraconazole.\" 519 (1992)","DOI":"10.1136\/vr.130.23.519-b"},{"key":"21","doi-asserted-by":"crossref","unstructured":"D. Shannon,  \"Vet Rec.\"  130, \"Treatment with itraconazole of penguins suffering from aspergillosis.\" 479 (1992)","DOI":"10.1136\/vr.130.21.479-b"},{"key":"22","doi-asserted-by":"crossref","unstructured":"HR Ashbee, RA Barnes, EM Johnson,  \"J Antimicrob Chemother.\"  69, \"Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology.\" 1162 (2014)","DOI":"10.1093\/jac\/dkt508"},{"key":"23","doi-asserted-by":"crossref","unstructured":"ML Goodwin  and RH Drew  \"J Antimicrob Chemother.\"  61, \"Antifungal serum concentration monitoring: an update.\" 17 (2008)","DOI":"10.1093\/jac\/dkm389"},{"key":"24","unstructured":"J Carpenter,  \"Exotic Animal Formulary.\"  ,  (2017)"}],"container-title":["Journal of Avian Medicine and Surgery"],"original-title":[],"deposited":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T12:01:47Z","timestamp":1793448107000},"score":1,"resource":{"primary":{"URL":"https:\/\/bioone.org\/journals\/journal-of-avian-medicine-and-surgery\/volume-34\/issue-1\/1082-6742-34.1.52\/Preliminary-Pilot-Study-of-Itraconazole-After-a-Single-Oral-Dose\/10.1647\/1082-6742-34.1.52.full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,29]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,3,1]]}},"URL":"https:\/\/doi.org\/10.1647\/1082-6742-34.1.52","relation":{},"ISSN":["1082-6742","1938-2871"],"issn-type":[{"value":"1082-6742","type":"print"},{"value":"1938-2871","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,29]]}}}